PB 3 of 2026

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2026 (No. 1)

 

National Health Act 1953

I, REBECCA RICHARDSON, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 98C(1) of the National Health Act 1953.

Dated 29 January 2026

REBECCA RICHARDSON
Assistant Secretary
PBS Listing, Pricing and Policy Branch
Technology Assessment and Access Division

Contents

1. Name

2. Commencement

3. Authority

4. Schedules

Schedule 1—Amendments

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

1 February 2026

1 February 2026

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)

[1] Schedule 4, after entry for Abiraterone and methylprednisolone in the form Pack containing 120 tablets abiraterone acetate 125 mg and 60 tablets methylprednisolone 4 mg

insert:

Abiraterone and prednisolone

Pack containing 56 tablets abiraterone acetate 500 mg and 56 tablets prednisolone 5 mg

[2] Schedule 4, after entry for Buprenorphine in the form Injection (modified release) 300 mg in 1.5 mL pre-filled syringe

insert:

Calcipotriol with betamethasone

Cream containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g